BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 38193092)

  • 1. The role of microRNAs involved in the disorder of blood-brain barrier in the pathogenesis of multiple sclerosis.
    Emami Nejad A; Mostafavi Zadeh SM; Nickho H; Sadoogh Abbasian A; Forouzan A; Ahmadlou M; Nedaeinia R; Shaverdi S; Manian M
    Front Immunol; 2023; 14():1281567. PubMed ID: 38193092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA in multiple sclerosis.
    Gao Y; Han D; Feng J
    Clin Chim Acta; 2021 May; 516():92-99. PubMed ID: 33545109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating microRNAs as biomarkers in progressive multiple sclerosis.
    Vistbakka J; Elovaara I; Lehtimäki T; Hagman S
    Mult Scler; 2017 Mar; 23(3):403-412. PubMed ID: 27246141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are circulating microRNAs peripheral biomarkers for Alzheimer's disease?
    Kumar S; Reddy PH
    Biochim Biophys Acta; 2016 Sep; 1862(9):1617-27. PubMed ID: 27264337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miRNAs in Microglia: Important Players in Multiple Sclerosis Pathology.
    Walsh AD; Nguyen LT; Binder MD
    ASN Neuro; 2021; 13():1759091420981182. PubMed ID: 33517686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Robust profiling of microRNAs and isomiRs in human plasma exosomes across 46 individuals.
    Karlsen TA; Aae TF; Brinchmann JE
    Sci Rep; 2019 Dec; 9(1):19999. PubMed ID: 31882820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Salivary miRNome: A Promising Biomarker of Disease.
    Tomei S; Manjunath HS; Murugesan S; Al Khodor S
    Microrna; 2021; 10(1):29-38. PubMed ID: 33845754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small non-coding RNAs as important players, biomarkers and therapeutic targets in multiple sclerosis: A comprehensive overview.
    Piket E; Zheleznyakova GY; Kular L; Jagodic M
    J Autoimmun; 2019 Jul; 101():17-25. PubMed ID: 31014917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNAs as active players in the pathogenesis of multiple sclerosis.
    Fenoglio C; Ridolfi E; Galimberti D; Scarpini E
    Int J Mol Sci; 2012 Oct; 13(10):13227-39. PubMed ID: 23202949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [MicroRNA in Body Fluids - Development of the Novel Plat Form for Cancer Therapeutics and Diagnosis].
    Takahashi RU; Prieto-Vila M; Kohama I; Ochiya T
    Gan To Kagaku Ryoho; 2018 Jun; 45(6):899-905. PubMed ID: 30026410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exosome-associated miRNA profile as a prognostic tool for therapy response monitoring in multiple sclerosis patients.
    Manna I; Iaccino E; Dattilo V; Barone S; Vecchio E; Mimmi S; Filippelli E; Demonte G; Polidoro S; Granata A; Scannapieco S; Quinto I; Valentino P; Quattrone A
    FASEB J; 2018 Aug; 32(8):4241-4246. PubMed ID: 29505299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical relevance of circulating cell-free microRNAs in ovarian cancer.
    Nakamura K; Sawada K; Yoshimura A; Kinose Y; Nakatsuka E; Kimura T
    Mol Cancer; 2016 Jun; 15(1):48. PubMed ID: 27343009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery and Evaluation of Extracellular MicroRNA Biomarkers in Plasma, Ascites, and Urine.
    Záveský L; Slanař O
    Methods Mol Biol; 2023; 2630():135-143. PubMed ID: 36689181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification and microRNA profiling of exosomes derived from blood and culture media.
    McDonald MK; Capasso KE; Ajit SK
    J Vis Exp; 2013 Jun; (76):e50294. PubMed ID: 23792786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating microRNAs as biomarkers for disease staging in multiple sclerosis.
    Gandhi R; Healy B; Gholipour T; Egorova S; Musallam A; Hussain MS; Nejad P; Patel B; Hei H; Khoury S; Quintana F; Kivisakk P; Chitnis T; Weiner HL
    Ann Neurol; 2013 Jun; 73(6):729-40. PubMed ID: 23494648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miRandola: extracellular circulating microRNAs database.
    Russo F; Di Bella S; Nigita G; Macca V; Laganà A; Giugno R; Pulvirenti A; Ferro A
    PLoS One; 2012; 7(10):e47786. PubMed ID: 23094086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miRNAs in multiple sclerosis: A clinical approach.
    Minutti-Zanella C; Bojalil-Álvarez L; García-Villaseñor E; López-Martínez B; Pérez-Turrent M; Murrieta-Álvarez I; Ruiz-Delgado GJ; Argüelles GJR
    Mult Scler Relat Disord; 2022 Jul; 63():103835. PubMed ID: 35533548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysregulated Network of miRNAs Involved in the Pathogenesis of Multiple Sclerosis.
    Dolati S; Marofi F; Babaloo Z; Aghebati-Maleki L; Roshangar L; Ahmadi M; Rikhtegar R; Yousefi M
    Biomed Pharmacother; 2018 Aug; 104():280-290. PubMed ID: 29775896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNAs in biofluids are novel tools for bladder cancer screening.
    Liu X; Liu X; Wu Y; Wu Q; Wang Q; Yang Z; Li L
    Oncotarget; 2017 May; 8(19):32370-32379. PubMed ID: 28423688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The emerging role of microRNAs in multiple sclerosis.
    Junker A; Hohlfeld R; Meinl E
    Nat Rev Neurol; 2011 Jan; 7(1):56-9. PubMed ID: 21151203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.